Head and Neck Cancer Information

Main Menu

Oncology Stocks

Head and Neck Cancer Information Center

Folder Conference Coverage

ASCO Review 2007: Supportive Care Issues in Head and Neck Cancer
Barbara A. Murphy, MD, Vanderbilt University, Vanderbilt Ingram Cancer Center

People Current Topics

Updates in the Management of Head and Neck
Marshall R. Posner, MD, Medical Director, Head and Neck Oncology Program, Dana-Farber Cancer Institute.
With Comments by David Raben, MD, University of Colorado Health Sciences Center.

Management Approaches in Head and Neck Cancer
David Raben, MD, University of Colorado Health Sciences Center

Pre-Clinical and Clinical Issues Regarding Head and Neck Cancer
David Raben, MD - University of Colorado Health Sciences Center

Head and Neck Melanoma
David H. Lawson, MD

New Approaches in the Treatment of Head and Neck Cancer
C. D. Buckner M.D.

Radiation Strategies for the Treatment of Head and Neck Cancer
John W. Reike MD, FACP Clinical Professor of Radiation Oncology, University of Washington and School of Medicine, Seattle Washington; Radiation Oncologist and Directory of Clinical Research, Overlake Hospital Cancer Center, Bellevue, Washington

News Latest Head and Neck Cancer News

Early-stage Head and Neck Cancer in Patients 80 Years of Age or Older Highly Treatable (11/19/2008)
Researchers from France have reported that patients 80 years of age or older with Stage I-II head and neck cancer have good outcomes following surgery or radiation therapy. The details of this study appeared in an early online publication in Cancer on October 17, 2008.

Long-term Incense Use Increases Risk of Cancer Upper Respiratory Tract Cancer (10/7/2008)
Researchers from Singapore have reported that long-term incense use increases the risk of squamous cell carcinoma of the respiratory tract. The details of this study appeared in the October 1, 2008 issue of Cancer.

Proteins in Saliva May Detect Oral Cancer (10/4/2008)
Researchers from the University of California at Los Angeles have reported that proteins detected from saliva may be effective in identifying the presence of oral cancer. These results were recently published in Clinical Cancer Research.

Chemoradiotherapy Effective for T 4 Laryngeal Cancer (9/12/2008)
Researchers from the University of Chicago have reported that chemoradiotherapy results in “promising control and functional outcomes” for patients with T4 laryngeal cancer. The details of this study were published in the September, 2008 issue of the Annals of Oncology.

Erbitux® Improves Survival in Head and Neck Cancer (9/11/2008)
Researchers affiliated with the EXTREME trial (Erbitux in First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer) have reported that the addition of Erbitux® (cetuximab) to platinum-fluorouracil based chemotherapy improves survival in patients with recurrent or metastatic head and neck cancer compared with chemotherapy only. The preliminary results of this randomized trial were presented at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO) and have now been published in the September 11, 2008 issue of the New England Journal of Medicine.

Head and Neck Cancer Drug Pipeline

What's in the pipeline for Head and Neck Cancer.

Newsletters

Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.